A Paris-based biotech company is turning heads so far during Tuesday’s premarket after the company reported year-over-year FY23 EPS results, according to a press release this morning. 

While we don’t usually get into the weeds with financials in the penny stock realm (when compared to widely covered mid or large cap stocks), these key pieces of fundamental information can create quite the frenzy for traders. 

Shares of Biophytis SA (Nasdaq:BPTS) are being aggressively bid up by traders as we head toward the opening bell, with shares currently bid at $0.4475/share (+39.80% implied open for sellers) at the time of writing. It should be an exciting session for this micro cap!

Biophytis SA is a France-based biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases.

Copyright © 2024 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.